CultHealth: 2022

CultHealth

261 5th Avenue, #1002; New York, NY 10016
646-430-9933 x805 • [email protected] • culthealth.com

QUICK FACTS

Accounts
Account wins 9
Active business clients 16

Brands by 2021 sales
Brand-product accounts held 19
$25 million or less 19

Services Mix
DTC/DTP advertising 45%
HCP advertising 35%
Interactive/digital 25%

Client Roster
AbbVie
AstraZeneca
Clovis Oncology
Foundation Consumer Healthcare
Novo Nordisk
Servier
Supernus

 

Privately owned Cult­Health is a full-service agency based in New York City. The leadership team describes Cult­Health as a rare type of agency that delivers high-level breakthrough DTC, truly distinctive HCP executions and programs, and world-class digital innovation and services.

“CultHealth develops brand communications strategies that inspire healthcare providers and patients to take action,” management says. “We execute across traditional channels such as broadcast television, print advertising, POC, and also omnichannel planning, leveraging digital communications, social media platforms, and technologies. CultHealth uses the power of creative thinking to improve health and save lives.”

According to agency leaders, 2021 was a year of tremendous growth in terms of its client roster, service offerings, and corresponding agency size. “Despite the continued challenges we collectively faced, the CultHealth management team worked tirelessly to ensure employees, clients and the surrounding businesses remained positioned for success,” they say.

Recent Accomplishments

In the past year, CultHealth significantly added to its already growing roster of clients, in addition to therapeutic area firsts for the agency, management says.

AbbVie tapped CultHealth to manage both DTC and HCP AOR assignments for the launch of its preventive migraine brand, Qulipta. “The powerful HCP campaign and the unique and highly visible DTC campaign have contributed to the brand’s rapid ascent toward category leadership,” management says.

The Qulipta win was quickly followed by HCP-AOR responsibilities for AbbVie’s acute migraine therapy, Ubrelvy, and agency executives say CultHealth continues to grow that brand’s success as well. CultHealth was also engaged by AstraZeneca to bolster the Fasenra HCP business, with AOR assignments spanning the U.S. and global markets, across severe asthma and nasal polyps indications.

The growth of CultHealth’s oncology division continued with HCP and DTP AOR assignments for Servier Pharmaceuticals’ Tibsovo brand, with the agency working on expanded indications for AML and a new indication launch for CCA in U.S. and global markets.

Heading into its tenth year of partnership with Novo Nordisk, CultHealth developed creative innovations with a breakthrough animated DTC campaign created for the launch of Rybelsus, the world’s first oral GLP-1 that is already experiencing incredible success and produced a celebrity-featured evolution for the iconic Ozempic brand, agency leaders say.

CultHealth’s digital division continued its rapid growth as Novo Nordisk consolidated digital AOR assignments for its GLP-1 portfolio with the shop.

And the agency ended the year earning a substantial HCP and DTC AOR win with Supernus for two of that marketer’s Parkinson’s disease therapies: Apokyn, and launch planning and development for the upcoming device-aided therapy, SPN-830.

Structure and Services

CultHealth is structured to be client-centric, adapting its process to fit into the clients’ ways of working, agency leaders say, adding, “By structuring agency teams to mirror client teams, the agency seamlessly works as an extension of the client marketing team.”

Internally, CultHealth has implemented structural alignments that have led to powerfully enhanced offerings, agency managers say. These include medical direction and strategic planning integrated into a common team, providing integrated scientific, business, and emotional insights and analysis; and a new data analytics division that was created as a “joint venture” between the digital and strategy departments, informing content and optimization efforts across all channels.

Services offered include HCP advertising; DTC/DTP advertising; digital/social media marketing; CRM; TEXTURE, a proprietary mobile CRM technology tool driving patient adherence; analytics; and market access communications.

Future Plans

Building on a heritage of innovative product creation, CultHealth will continue to enhance and promote TEXTURE, the agency’s proven mobile CRM platform for patient adherence, and will also launch several new products this year designed to grow brand value,” the leadership team says. The agency will also expand the rollout of its data analytics offering, providing broader services to more of its clients.

CultHealth is building out a new office space to accommodate the team’s growth, while redesigning the layout of an office built for today’s work style, with an emphasis on collaboration spaces and hybrid teams.

Philanthropy/Citizenship

CultHealth’s commitment to DEI initiatives has become a driving force both internally and externally,” according to the leadership team.

Internally, the agency implemented policies to promote growing diversity among the company’s ranks and has initiated a DEI committee to continually identify ways of creating a more inclusive culture.

Externally, CultHealth’s CEO joined the board of directors of the nonprofit Momentum and Value for People of Color (www.mvpoc.org), and the agency followed suit welcoming MVP as a pro-bono client, producing events, websites, social content, and in general supporting MVP’s mission of creating opportunities for minority youth.